Banque Cantonale Vaudoise - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Banque Cantonale Vaudoise ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$736
-19.8%
16,208
-1.0%
0.04%
-14.0%
Q2 2023$918
+29.5%
16,366
+4.4%
0.04%
+22.9%
Q1 2023$709
+10.6%
15,674
-0.6%
0.04%
+2.9%
Q4 2022$641
-99.9%
15,772
+0.9%
0.03%
-41.4%
Q3 2022$1,022,000
+6.1%
15,639
-1.3%
0.06%
+16.0%
Q2 2022$963,000
+262.0%
15,844
+274.7%
0.05%
+354.5%
Q1 2022$266,000
+1.9%
4,229
+22.8%
0.01%
+10.0%
Q4 2021$261,000
-42.6%
3,443
-15.3%
0.01%
-50.0%
Q3 2021$455,000
-35.6%
4,066
-6.8%
0.02%
-35.5%
Q2 2021$706,000
+22.8%
4,363
-7.6%
0.03%
+6.9%
Q1 2021$575,000
-63.5%
4,723
-54.1%
0.03%
-66.7%
Q4 2020$1,575,000
+109.7%
10,282
+14.6%
0.09%
+81.2%
Q3 2020$751,000
+17.9%
8,972
+3.6%
0.05%
+4.3%
Q2 2020$637,000
+91.9%
8,664
+10.6%
0.05%
+64.3%
Q1 2020$332,000
-36.5%
7,831
-8.8%
0.03%
-22.2%
Q4 2019$523,0008,5890.04%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$31,294,00031.24%
NEA Management Company, LLC 1,590,002$365,593,00010.56%
Ariose Capital Management Ltd 37,900$2,379,0009.30%
ARK Investment Management 9,404,071$590,294,0002.46%
NIA IMPACT ADVISORS, LLC 80,082$5,027,0002.44%
Nikko Asset Management Americas, Inc. 4,619,747$291,044,0002.14%
PLUSTICK MANAGEMENT LLC 50,000$3,139,0001.98%
Integral Health Asset Management, LLC 120,000$7,532,0001.96%
Valiant Capital Management, L.P. 240,683$15,108,0001.73%
Deuterium Capital Management, LLC 18,000$1,130,0001.45%
View complete list of CRISPR THERAPEUTICS AG shareholders